Abstract
Data suggests that peripheral and sacral neuromodulation are minimally invasive surgical interventions to address and improve both urinary and bowel symptoms in patients with neurogenic bladder and/or bowel. There is lack of level one evidence and there is moderate data supporting the use of these therapies to address overactive bladder symptoms in patients with neurogenic bladder. There is still controversy about their utility for urinary retention, and data is limited regarding treatment of neurogenic bowel. Limitations include small sample size, heterogeneous neurologic etiologies of study populations, and measurement of different outcomes, and most studies are retrospective analyses. Nonetheless more contemporary data suggests promising outcomes in specific situations that could statistically and clinically improve urinary and bowel symptoms in patients with spinal cord injury and multiple sclerosis. Current research is studying the effect of early utilization of sacral neuromodulation after spinal cord injury. Targeting of specific stages of a neurologic injury will address the question of who is an optimal candidate and may ultimately benefit from this intervention. Avoiding the neurologic impairment that occurs at the bladder and bowel level may prevent detrimental changes in organ physiology and improve symptoms in the long term.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Madersbacher H. Konservative Therapie der neurogenen Blasendysfunctktion. Urologe. 1999;38:24–9.
Tanagho EA, Schmidt RA, Orvis BRNeural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol [Internet]. 1989;142(2 Pt 1):340–5. http://www.ncbi.nlm.nih.gov/pubmed/2787411.
Bross S, Braun ÆPM, Weiß ÆJ, Martinez FJ, Thomas PÆ, Seif C, et al. The role of the carbachol test and concomitant diseases in patients with nonobstructive urinary retention undergoing sacral neuromodulation. World J Urol. 2003:346–9.
Fisch M, Wammack R, Hohenfellner R. The sigma rectum pouch (Mainz pouch II). World J Urol [Internet]. 1996 [cited 2016 Feb 12];14(2):68–72. http://www.ncbi.nlm.nih.gov/pubmed/8731120.
Dijkema HE, Weil EH, Mijs PT, Janknegt RA. Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications. Eur Urol [Internet]. 1993;24(1):72–6. http://www.ncbi.nlm.nih.gov/pubmed/8396034.
Groat WC De Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol [Internet]. 2015;5(1):327–96. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480926/pdf/nihms697977.pdf.
Bartley JM, Killinger KA, Boura JA, Gupta P, Gaines N, Gilleran JP, et al. The impact of prior back surgery on neuromodulation outcomes: a review of over 500 patients. Neurourol Urodyn. 2017;36(6):1535–42.
Appell RA, Dmochowski RR, Blaivas JM, Gormley EA, Karram MM, Juma S, et al. Guideline for the surgical management of female stress urinary incontinence: 2009 update. AUA Guidel. 2009;799.
Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58(6):865–74.
Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology [Internet]. 2013;81(4):738–43. https://doi.org/10.1016/j.urology.2012.11.073.
Wöllner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord [Internet]. 2016;54(2):137–40. http://www.ncbi.nlm.nih.gov/pubmed/26215913.
Chaabane W, Guillotreau J, Castel-Lacanal E, Abu-Anz S, De Boissezon X, Malavaud B, et al. Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn [Internet]. 2011;30(4):547–50. http://www.ncbi.nlm.nih.gov/pubmed/21488095.
Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F, et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol. 2001;166(2):541–5.
Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, Chancellor MB, Richard F, Denys P. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol. 2000;164(5):1476–80.
Wallace PA, Lane FL, Noblett KL. Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol [Internet]. 2007;197(1):96.e1–5. http://www.ncbi.nlm.nih.gov/pubmed/17618775.
Daniels DH, Powell CR, Braasch MR, Kreder KJ. Sacral neuromodulation in diabetic patients : success and complications in the treatment of voiding dysfunction. Neurourol Urodyn. 2010;29(4):578–81.
Marinkovic SP, Gillen LM. Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J. 2010;21(2):223–8.
Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol. 2012;30(1):123–8.
Lombardi G, Musco S, Celso M, Del Corso F, Del Popolo G. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord [Internet]. 2014;52(August 2013):1–5. http://www.ncbi.nlm.nih.gov/pubmed/24394604.
Nortvedt MW, Riise T, Frugård J, Mohn J, Bakke A, Skår AB, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler [Internet]. 2007;13(1):106–12. http://www.ncbi.nlm.nih.gov/pubmed/17294618.
Bosch JLHR, Groen J. Early reports. Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients. The Lancet. 1996;348:717–9.
Lombardi G, Del Popolo G. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms. Spinal Cord. 2009;47(6):486–91. https://doi.org/10.1038/sc.2008.172
Sievert K-D, Amend B, Gakis G, Toomey P, Badke A, Kaps HP, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol [Internet]. 2010;67(1):74–84. http://www.ncbi.nlm.nih.gov/pubmed/20186953.
Knüpfer SC, Liechti MD, Mordasini L, Abt D, Engeler DS, Wöllner J, et al. Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction. BMC Urol [Internet]. 2014;14(1):65. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4139491&tool=pmcentrez&rendertype=abstract.
Arlen AM, Powell CR, Kreder KJ. Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgery. Sci World J [Internet]. 2011;11:142–6. http://www.ncbi.nlm.nih.gov/pubmed/21258757.
Sanford MT, Suskind AM. Neuromodulation in neurogenic bladder. Transl Androl Urol [Internet]. 2016;5(1):117–26. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4739974.
Matzel KE, Stadelmaier U, Hohenfellner M, Gall FP. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet (London, England) [Internet]. 1995;346(8983):1124–7. http://www.ncbi.nlm.nih.gov/pubmed/7475602.
Worsøe J, Rasmussen M, Christensen P, Krogh K. Neurostimulation for neurogenic bowel dysfunction. Gastroenterol Res Pract. 2013;2013:1.
Ganio E, Luc AR, Clerico G, Trompetto M. Sacral nerve stimulation for treatment of fecal incontinence: a novel approach for intractable fecal incontinence. Dis Colon Rectum. 2001;44(5):619–29.
Rosen HR, Urbarz C, Holzer B, Novi G, Schiessel R. Sacral nerve stimulation as a treatment for fecal incontinence. Gastroenterology. 2001;121:536–41.
Jarrett MED, Matzel KE, Christiansen J, Baeten CGMI, Rosen H, Bittorf B, et al. Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse. Br J Surg [Internet]. 2005;92(6):734–9. http://www.ncbi.nlm.nih.gov/pubmed/15838899.
Holzer B, Rosen HR, Novi G, Ausch C, Hölbling N, Schiessel R. Sacral nerve stimulation for neurogenic faecal incontinence. Br J Surg. 2007;94(6):749–53.
Gstaltner K, Rosen H, Hufgard J, Märk R, Schrei K. Sacral nerve stimulation as an option for the treatment of faecal incontinence in patients suffering from cauda equina syndrome. Spinal Cord [Internet]. 2008;46(9):644–7. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18317481&retmode=ref&cmd=prlinks%5Cnpapers3://publication/doi/10.1038/sc.2008.6
Lansen-Koch SMP, Govaert B, Oerlemans D, Melenhorst J, Vles H, Cornips E, et al. Sacral nerve modulation for defaecation and micturition disorders in patients with spina bifida. Color Dis. 2012;14(4):508–14.
Gupta P, Ehlert MJ, Sirls LT, Peters KM. Percutaneous tibial nerve stimulation and sacral neuromodulation: an update. Curr Urol Rep [Internet]. 2015;16(2):4. http://www.ncbi.nlm.nih.gov/pubmed/25630918.
Gaziev G, Topazio L, Iacovelli V, Asimakopoulos A, Di Santo A, De Nunzio C, et al. Percutaneous Tibial Nerve Stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol [Internet]. 2013;13:61. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4222591&tool=pmcentrez&rendertype=abstract.
Kabay S, Kabay SC, Yucel M, Ozden H, Yilmaz Z, Aras O, et al. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn [Internet]. 2009;28(8):964–8. http://www.ncbi.nlm.nih.gov/pubmed/19373898.
Kabay SC, Kabay S, Yucel M, Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Neurourol Urodyn [Internet]. 2009;28(1):62–7. http://www.ncbi.nlm.nih.gov/pubmed/18837432.
de Sèze M, Raibaut P, Gallien P, Even-Schneider A, Denys P, Bonniaud V, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn [Internet]. 2011;30(3):306–11. http://www.ncbi.nlm.nih.gov/pubmed/21305588.
Monteiro ÉS, De Carvalho LBC, Fukujima MM, Lora MI, Do Prado GF. Electrical stimulation of the posterior tibialis nerve improves symptoms of poststroke neurogenic overactive bladder in men: a randomized controlled trial. Urology. 2014;84(3):509–14.
Chen G, Liao L, Li Y. The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury. Int Urol Nephrol. 2015;47(3):451–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Romo, P.G.B., Gupta, P. (2018). Neuromodulation in Neurourology. In: Dmochowski, R., Heesakkers, J. (eds) Neuro-Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-90997-4_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-90997-4_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90995-0
Online ISBN: 978-3-319-90997-4
eBook Packages: MedicineMedicine (R0)